ESCMID Global 2026: Zelicapavir demonstrates benefits for high-risk adults with RSV
At the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2026 conference, Chris Harris from Enanta Pharmaceuticals presented…
Infectious Disease
-
-
ESCMID Global 2026: Adibelivir emerges as potential disease-modifying therapy for HSV
Herpes simplex viruses (HSV) are common infections caused mainly by HSV-1 (usually oral) and HSV-2 (usually genital), although either type…
-
UK health authorities join forces to champion foreign infectious disease trials
Health divisions within the UK government and British non-profit organisations have banded together to support infectious disease trials in Africa,…
-
GSK’s oncology and HIV drugs drive 7% sales rise in 2025
GSK has posted positive sales results for fiscal year 2025 (FY2025) as the company’s new CEO, Luke Miels, takes the…
-
JPM26: Enanta outlines strategy to lead in RSV therapeutics
At the 44th Annual J.P. Morgan Healthcare Conference, Enanta Pharmaceuticals discussed its respiratory syncytial virus (RSV) portfolio and the need…
-
“Reckless and harmful”: experts weigh in on CDC’s autism-vaccine link stance
The Centers for Disease Control and Prevention (CDC) has updated its website to state that there could be a link…
-
MSD bets big on flu antivirals with $9.2bn buyout of Cidara
MSD has agreed to acquire Cidara Therapeutics in a $9.2bn deal, adding a new long-lasting infectious disease drug technology to…
-
Flu vaccine uptake increases 28% in England
The number of people receiving a flu vaccine across England has increased by over a quarter, as cases of both…
-
Basilea in line for $159m of US federal funding for UTI antibiotic pill
The Biomedical Advanced Research and Development Authority (BARDA) in the US will support Basilea’s development of a new type of…
-
US Government signs $56m smallpox/mpox vaccine order despite political disarray
The US Government has ordered $56m worth of mpox/smallpox vaccines to bolster public health preparedness, despite wider uncertainty in the…
